Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease
New studies shed some light on the function of sleep in animals, with interesting implications for HD research
Biomarkers and preparing for trials: the third & final day of the 2014 Huntington's Disease Therapeutics Conference
Cells, circuits and systems: day 2 of the 2014 HD Therapeutics conference
HDBuzz reports from the opening day of science sessions at the 2014 HD Therapeutics Conference in Palm Springs.
Results are in for a clinical trial testing the drug PBT2 for HD. Are the claims in the announcement justified?
A new study claims that high-dose creatine "slows the onset of Huntington Disease". How much hope and how much hype?
Researchers identify Gpx1, a protein that may be protective in HD. An existing drug can mimic its antioxidant effect.
There is copper in your brain! Check out how copper and the Huntington’s disease protein are partners in crime.
Roche's 'brain shuttle' sneaks drugs past the blood-brain barrier. Could it work for HD gene silencing drugs?
A recent HD animal study reveals that a small molecule drug could be an effective “Trk” to target for HD therapeutics